Related Experiment Video

Updated: Jun 30, 2026

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

[Metalloproteinases in meningoencephalitis]

Ewa Pastuszka1, Agata Pabin, Marek Radkowski

  • 1Zakład Immunopatologii Chorób Zakaźnych i Pasozytniczych, Akademii Medycznej w Warszawie. . evp@vp.pl

Przeglad Epidemiologiczny
|September 24, 2008
PubMed

Insights

Matrix-metalloproteinases (MMP) are implicated in the severe neurological damage seen in meningoencephalitis. Understanding MMP activity could lead to better diagnostic markers and treatments for this devastating brain infection.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Context:

  • Meningoencephalitis is a severe brain infection with high mortality and significant long-term neurological deficits.
  • Bacterial meningoencephalitis has a mortality rate of approximately 25%, with up to 50% of survivors experiencing lasting neurological or neuropsychological issues.

Purpose:

  • To explore the role of matrix-metalloproteinases (MMP) in the pathogenesis of meningoencephalitis.
  • To investigate how MMPs, particularly gelatinases (MMP-2, MMP-9), contribute to blood-brain barrier damage and neurological complications.

Summary:

  • Matrix-metalloproteinases (MMP), enzymes involved in extracellular matrix remodeling, are implicated in meningoencephalitis pathogenesis.
  • Gelatinases (MMP-2, MMP-9) degrade collagen IV, playing a key role in inflammatory brain diseases and disease spread.
  • Infections can elevate MMP levels by increasing secretion or decreasing inhibitor function, highlighting their importance in disease progression.

Impact:

  • Identifying MMPs' role may lead to novel diagnostic and prognostic markers for meningoencephalitis.
  • Targeting MMP activity could offer new therapeutic strategies to mitigate the severe outcomes of meningoencephalitis.

More Related Videos

Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS09:51

Standards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MS

Published on: April 13, 2016

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells09:35

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells

Published on: May 19, 2020

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...